These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 844195)

  • 1. Blood glucosylceramide levels in Gaucher's disease and its distribution amongst lipoprotein fractions.
    Dawson G; Oh JY
    Clin Chim Acta; 1977 Feb; 75(1):149-53. PubMed ID: 844195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycosphingolipids of human plasma lipoproteins.
    Clarke JT
    Can J Biochem; 1981 Jun; 59(6):412-7. PubMed ID: 6794884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of peripheral blood in an outpatient with atypical Gaucher's disease type 1 like myelodysplastic syndrome.
    Taketomi T; Uemura K; Hara A; Saito H
    Jpn J Exp Med; 1989 Apr; 59(2):85-8. PubMed ID: 2746973
    [No Abstract]   [Full Text] [Related]  

  • 4. Accumulation of lactosyl ceramide in leukocytes of patients with adult Gaucher's disease.
    Klibansky C; Ossimi Z; Matoth Y; Pinkhas J; de Vries A
    Clin Chim Acta; 1976 Oct; 72(1):141-6. PubMed ID: 975565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum lipoproteins in the pathogenesis of Gaucher disease.
    Dawson G; Kwok BC; Nishigaki M; Shen BW
    Prog Clin Biol Res; 1982; 95():253-65. PubMed ID: 7122636
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutral glycosphingolipids of serum lipoproteins in Fabry's disease.
    Clarke JT; Stoltz JM; Mulcahey MR
    Biochim Biophys Acta; 1976 May; 431(2):317-25. PubMed ID: 181056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoprotein responses to enzyme-replacement in Gaucher's disease.
    Cenarro A; Pocovi M; Giraldo P; Garcia-Otin AL; Ordovas JM
    Lancet; 1999 Feb; 353(9153):642-3. PubMed ID: 10030334
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of neutral glycosphingolipids in human plasma.
    van den Bergh FA; Tager JM
    Biochim Biophys Acta; 1976 Sep; 441(3):391-402. PubMed ID: 184824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10.
    Allen MJ; Myer BJ; Khokher AM; Rushton N; Cox TM
    QJM; 1997 Jan; 90(1):19-25. PubMed ID: 9093585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy.
    Gornati R; Bembi B; Tong X; Boscolo R; Berra B
    Clin Chim Acta; 1998 Mar; 271(2):151-61. PubMed ID: 9565330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.
    Vitner EB; Farfel-Becker T; Eilam R; Biton I; Futerman AH
    Brain; 2012 Jun; 135(Pt 6):1724-35. PubMed ID: 22566609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and metabolic abnormalities in Gaucher's disease.
    Aerts JM; Hollak CE
    Baillieres Clin Haematol; 1997 Dec; 10(4):691-709. PubMed ID: 9497858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the pathogenesis of Gaucher's disease: tissue distribution and biliary excretion of [14C]L-glucosylceramide in rats.
    Tokoro T; Gal AE; Gallo LL; Brady RO
    J Lipid Res; 1987 Aug; 28(8):968-72. PubMed ID: 3668390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An adult form of type-I. Gaucher's disease].
    Múzes G; Pitlik E; Gohér A; Somogyi A; Tulassay Z
    Orv Hetil; 2000 Mar; 141(13):669-73. PubMed ID: 10774238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating levels of transcobalamin ii in gaucher's disease.
    Gilbert HS; Weinreb N
    N Engl J Med; 1976 Nov; 295(20):1096-101. PubMed ID: 62278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 27-year experience with splenectomy for Gaucher's disease.
    Fleshner PR; Aufses AH; Grabowski GA; Elias R
    Am J Surg; 1991 Jan; 161(1):69-75. PubMed ID: 1987860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of plasma neutral glycosphingolipids by high performance liquid chromatography of their perbenzoyl derivatives.
    Ullman MD; McCluer RH
    J Lipid Res; 1977 May; 18(3):371-8. PubMed ID: 405444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of acute infantile Gaucher's disease. Study of plasmatic, erythrocytic and leukocytic lipids].
    Giardini O; Antonelli M; Castro M; Andreuzzi A
    Minerva Pediatr; 1977 Feb; 29(3):161-4. PubMed ID: 846465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.